# Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.

> **NCT00405548** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 41 (actual)

## Conditions studied

- Left Ventricular Diastolic Dysfunction

## Interventions

- **DRUG:** BNP (nesiritide)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00405548
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-04
- **Final completion:** 2012-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405548, "Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00405548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*